Cancer Research UK logo.
SearchDonate
  • Search

A study looking at targeting chemotherapy to the liver using focused ultrasound (TARDOX)

Overview

Cancer types:

Cancer spread to the liver, Liver cancer, Secondary cancers

Status:

Results

Phase:

Phase 1

Details

This study was for people with liver cancer or with cancer that had spread to the liver from another part of the body (secondary liver cancer).

Recruitment start: 27 June 2014

Recruitment end: 30 March 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Mark Middleton

Supported by

Celsion Corporation

Oxford University Hospitals NHS Trust

University of Oxford

NIHR Oxford Biomedical Research Centre

Oxford Biomedical Research Centre

Oxford Centre for Drug Delivery Devices

Engineering and Physical Sciences Research Council (EPSRC)

Last reviewed: 20 November 2018

CRUK internal database number: 14064

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.